Sartorius USA
在场
Sartorius USA 的所有者是 Sartorius.
是其中之一......
Sartorius 是一家在股票代码 SRT (DE) 下上市的公司。
Sartorius 在 8 个国家有直接业务。Sartorius 拥有 10家子公司，其中包括 Albumedix、CellGenix 和 Sartorius Belgium。
他们在：
涉及Sartorius的并购和融资。
- Sartorius has announced the acquisition of PolyPlus Transfection (公布2023四月4号).
高管
查看带有其 4 名主要高管的组织结构图
Sartorius USA 搜索最多的简介
- Maurice Phelan, President
- Ric Kositzke, Senior Director, Digital Marketing
- Matthew Lessler, Head of Finance
高管在Sartorius变化
- Joachim Kreuzburg, Chief Executive Officer, 将于 202510月31 退休 (新闻发布的2024七月3号).
创建提醒
跟踪 Sartorius USA 的高管变动
生物技术
Sartorius 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Evommune 刚刚宣布为 115 筹款数百万美元。 (公布2024十一月4号).
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
生物技术 行业的其他推荐联系人
消息
Sartorius USA 的最新新闻稿
- Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024
- Nine-month results in line with expectations: sales revenue almost at prior-year level; orders on the rise; robust profitability; increased cash flow
- Sartorius Stedim Biotech adjusts its guidance for fiscal year 2024 and presents results for H1 2024
- Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024
- Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive
- Half-year results 2024 of Sartorius Stedim Biotech
- Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret
- Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office
- Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification
- Sartorius opens new Center of Excellence for bioanalytics in Ann Arbor
- View more press releases Close
通过电子邮件
